ECCO's Educational Committee and the e-Learning Taskforce have prepared an IBD Curriculum that will serve as the framework for ECCO's educational activities, particularly the e-CCO e-learning tools.
The goal was to create a concise yet complete curriculum, outlining what gastroenterologists need to know to develop expertise in the IBD field.
It is a true ECCO document, developed with participation of all ECCO Officers and the National Representatives.
ECCO IBD Curriculum: Advanced training in the diagnosis and management of inflammatory bowel disease
1. General Understanding of Disease
Understanding the state of knowledge of pathogenesis of IBD, and the principles underlying treatment
1.1. Knows the science underlying the pathogenesis of IBD, in particular relating to genetic and environmental factors involved, and differences between Ulcerative Colitis (UC) , Crohn's Disease (CD) and IBD unclassified
Intestinal immunity and the epithelial barrier, IBD Boot Camp, 2014
e-Course: Introduction to IBD, ECCO e-Course, 2014
Use of Nutritional therapy in IBD, ECCO Talking Heads, 2014
IBD: The role of the exposome , 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
The genetics of IBD, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
The microbiome and IBD, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
Mechanisms of damage and repair, ECCO Congress Scientific Programme, 2015
The microbiome in the pathogenesis and therapy of IBD, ECCO Congress Scientific Programme, 2015
Impact of lifestyle changes on disease course, ECCO Congress Scientific Programme, 2015
Epigenetics of IBD, ECCO Congress Scientific Programme, 2015
Mechanisms by which inflammation resolves, ECCO Congress Scientific Programme, 2016
The microbiome and geographical spread of IBD , ECCO Congress Scientific Programme, 2016
Diagnosis, anatomy and physiology in IBD, 8th N-ECCO School, 2017
Exposome , 15th IBD Intensive Advanced Course, 2017
Genetics , 15th IBD Intensive Advanced Course, 2017
Inflammatory pathways , 15th IBD Intensive Advanced Course, 2017
Nutrition and Food additives, ECCO Congress Scientific Programme, 2017
Everyday poisons: Smoking, pollution, stress, sedentary lifestyle , ECCO Congress Scientific Programme, 2017
Genetics and function in IBD: The missing link?, ECCO Congress Scientific Programme, 2017
Epigenetics in complex diseases, ECCO Congress Scientific Programme, 2017
The forgotten populations in the gut, ECCO Congress Scientific Programme, 2017
Microbiome reality check - looking beyond the hype, ECCO Congress Scientific Programme, 2017
1.2. Understands the natural history of UC and CD, including its variability and the impact of therapy on the natural history
Activity indices for IBD, IBD Boot Camp, 2014
Mechanisms of damage and repair, ECCO Congress Scientific Programme, 2015
The true cost of IBD care, ECCO Congress Scientific Programme, 2015
Epidemiology of IBD, 1st H-ECCO IBD Masterclass, 2016
Ulcerative Colitis, ECCO Guidelines, 2016
Crohn's Disease, ECCO Guidelines, 2016
Are we truly changing disease course with current strategies?, ECCO Congress Scientific Programme, 2017
1.3. Understands the importance of communicating with patients and educating them about their disease and its natural history as well as the principals of management
Intestinal immunity and the epithelial barrier, IBD Boot Camp, 2014
e-Course: Introduction to IBD, ECCO e-Course, 2014
Use of Nutritional therapy in IBD, ECCO Talking Heads, 2014
Care or action plans for patients , ECCO Congress Scientific Programme, 2016
Treating the patient vs. treating the disease, ECCO Congress Scientific Programme, 2017
1.4. Understands the basic immunology of IBD and mechanism of action (as far as it is understood) and rationale for using different treatment types in IBD
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
The management of IBD, IBD Blue Book, 2014
Tissue healing and current biological therapy, 4th S-ECCO IBD Masterclass, 2015
The science which will impact our IBD clinic, ECCO Congress Scientific Programme, 2015
Exposome , 15th IBD Intensive Advanced Course, 2017
Genetics , 15th IBD Intensive Advanced Course, 2017
Inflammatory pathways , 15th IBD Intensive Advanced Course, 2017
IL-23 and beyond, ECCO Congress Scientific Programme, 2017
JAK-inhibitors, ECCO Congress Scientific Programme, 2017
S1P, ECCO Congress Scientific Programme, 2017
Anti IL12/IL23 compounds, ECCO Congress Scientific Programme, 2017
1.5. Able to use knowledge of modifiable and non-modifiable risk factors to underlie management decisions and to stratify risk for patients.
How to communicate risks of disease or treatment with a patient, ECCO Talking Heads, 2014
Travelling with IBD, ECCO Talking Heads, 2014
Management of patients on thiopurines, ECCO Talking Heads, 2014
Therapeutic drug monitoring, ECCO Talking Heads, 2015
Influence of the inflammatory burden on pharmacokinetics of biologicals, ECCO Congress Scientific Programme, 2015
IBD Drugs in Pregnancy - Current Controversies, ECCO Talking Heads, 2016
2. Diagnosis
To understand the methods of diagnosis including major differentials and to provide advice in cases where the diagnosis is unclear
2.1. Knows the major differential diagnoses of IBD, including infection (viral, bacterial, and amoebic), vasculitis, ischaemia, Behcet's disease, irritable bowel syndrome (IBS) etc.
Paediatric UC, ECCO Guidelines, 2012
Histopathology, ECCO Guidelines, 2013
Paediatric CD, ECCO Guidelines, 2014
e-Course: Endoscopy for IBD, ECCO e-Course, 2014
The differential diagnosis of IBD , IBD Blue Book, 2014
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
Endoscopy and imaging in IBD, IBD Boot Camp, 2014
Laboratory interpretation in IBD, 9th N-ECCO Network Meeting , 2015
New biomarkers and their roles , 9th N-ECCO Network Meeting , 2015
Very early onset IBD, ECCO Talking Heads, 2015
Should we treat CMV in patients with UC? , ECCO Congress Scientific Programme, 2016
Other viral complications in clinical practice , ECCO Congress Scientific Programme, 2016
Clinical and endoscopic features of IBD, 1st H-ECCO IBD Masterclass, 2016
What does the gastroenterologist want to know from the pathologist?, 1st H-ECCO IBD Masterclass, 2016
Basic principles of histological IBD diagnosis, 1st H-ECCO IBD Masterclass, 2016
The classic histology of Ulcerative Colitis and Crohn's Disease, 1st H-ECCO IBD Masterclass, 2016
Non-IBD colitides, 1st H-ECCO IBD Masterclass, 2016
Diagnosis of dysplasia (Tandem talk), 1st H-ECCO IBD Masterclass, 2016
Imaging modalities in IBD [soon], IBD Blue Book, 2016
Ulcerative Colitis, ECCO Guidelines, 2016
Crohn's Disease, ECCO Guidelines, 2016
2.2. Knows the appropriate investigations to distinguish the above, and their limitations
The ideal pathology report, 1st H-ECCO IBD Masterclass, 2016
2.3. Knows the differential when a patient with known IBD presents with symptoms including - active IBD, bacterial overgrowth, bile salt malabsorption, obstruction, enteric infection, sepsis, non-inflammatory symptoms (IBS) etc.
The management of IBD, IBD Blue Book, 2014
The differential diagnosis of IBD , IBD Blue Book, 2014
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
The use of Biomarkers in IBD, IBD Boot Camp, 2014
Other viral complications in clinical practice , ECCO Congress Scientific Programme, 2016
Ulcerative Colitis vs. Crohn's Disease in difficult cases, 1st H-ECCO IBD Masterclass, 2016
Ulcerative Colitis, ECCO Guidelines, 2016
Crohn's Disease, ECCO Guidelines, 2016
Disease monitoring in IBD [soon], IBD Blue Book,
3. Assessment
The assessment of disease activity and extent including complications
Strictures: Inflammatory or fibrotic?, 4th S-ECCO IBD Masterclass, 2015
Activity in IBD, 1st H-ECCO IBD Masterclass, 2016
3.1. Understands the appropriate investigations for assessing disease activity and extent including:
· Inflammatory markers in blood and stool
· Upper and lower GI endoscopy / capsule endoscopy / enteroscopy
· Imaging techniques, including: CT, MRI, barium imaging and ultrasound
Imaging, ECCO Guidelines, 2012
Histopathology, ECCO Guidelines, 2013
e-Course: Endoscopy for IBD, ECCO e-Course, 2014
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
Endoscopy and imaging in IBD, IBD Boot Camp, 2014
The use of Biomarkers in IBD, IBD Boot Camp, 2014
Mucosal Healing in Crohn's Disease, IBD Boot Camp, 2014
Patient-reported outcomes, ECCO Congress Scientific Programme, 2016
Imaging modalities in IBD [soon], IBD Blue Book, 2016
Disease monitoring in IBD [soon], IBD Blue Book,
3.2. Phenotypic classification of CD and UC
Paediatric UC, ECCO Guidelines, 2012
Paediatric CD, ECCO Guidelines, 2014
The differential diagnosis of IBD , IBD Blue Book, 2014
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
Ulcerative Colitis, ECCO Guidelines, 2016
Crohn's Disease, ECCO Guidelines, 2016
3.3. Understands the circumstances in which disease activity and extent should be reassessed.
The management of IBD, IBD Blue Book, 2014
Surgery for IBD, IBD Blue Book, 2014
Malignancies, ECCO Guidelines, 2015
Mucosal healing - Is it the holy grail?, ECCO Congress Scientific Programme, 2016
Ulcerative Colitis, ECCO Guidelines, 2016
Crohn's Disease, ECCO Guidelines, 2016
Disease monitoring in IBD, IBD Blue Book, [soon]
3.4. Knowledge of complications and appropriate action in terms of investigation and management
Opportunistic Infections, ECCO Guidelines, 2014
Anaemia, ECCO Guidelines, 2015
Surgical UC, ECCO Guidelines, 2015
Surgical CD, ECCO Guidelines, 2016
4. IBD Multidisciplinary Team (MDT)
To understand the importance of the MDT in decision making, and how to use it to maximise the quality of patient care
What's hot in IBD Pathology?, 1st H-ECCO IBD Masterclass, 2016
Nursing roles in IBD management, 8th N-ECCO School, 2017
4.1. Understands the importance of multidisciplinary decision making including when radiological, histopathological and surgical opinions should be sought.
Imaging, ECCO Guidelines, 2012
The management of IBD, IBD Blue Book, 2014
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
Surgery for IBD, IBD Blue Book, 2014
Surgical UC, ECCO Guidelines, 2015
Imaging modalities in IBD [soon], IBD Blue Book, 2016
Disease monitoring in IBD [soon], IBD Blue Book, [soon]
Surgical CD, ECCO Guidelines, 2016
4.2. Understands the importance of involving other specialities in the care of IBD.
Reproduction & Pregnancy, ECCO Guidelines, 2015
Extra-Intestinal Manifestations, ECCO Guidelines, 2016
IBD Drugs in Pregnancy - Current Controversies, ECCO Talking Heads, 2016
e-Course: Extra-intestinal Manifestations [soon], ECCO e-Course, [soon]
4.3. Recognises the importance of other healthcare professionals in providing high quality care including nurses, dieticians, stoma therapists, psychologists, and pharmacists
How to communicate risks of disease or treatment with a patient, ECCO Talking Heads, 2014
The central role of the IBD nurse in the multidisciplinary management , ECCO Congress Scientific Programme, 2015
e-Course: Nursing Perspective - Anaemia, ECCO e-Course, 2016
e-Course: Nursing Perspective - UC, ECCO e-Course, 2016
Care or action plans for patients , ECCO Congress Scientific Programme, 2016
Nursing perspective: Stoma & Pouch, ECCO Talking Heads, 2016
Nutrition & Paediatrics - topic: TBD, ECCO Talking Heads, 2017
5. Surgery and IBD
To understand the indications for surgery in IBD and the importance of good medical- surgical liaison in good decision-making
e-Course: Fistulising CD, ECCO e-Course, 2014
Surgery for IBD, IBD Blue Book, 2014
How to manage pouchitis, IBD Boot Camp, 2014
Surgical UC, ECCO Guidelines, 2015
Laparoscopy in complex cases, 4th S-ECCO IBD Masterclass, 2015
LIRIC (Ileocolic resection vs. anti-TNF), 4th S-ECCO IBD Masterclass, 2015
ACCURE/PASSION (Appendectomy for UC), 4th S-ECCO IBD Masterclass, 2015
Medication and postoperative complications in UC, 4th S-ECCO IBD Masterclass, 2015
Medication and postoperative complications in Crohn's , 4th S-ECCO IBD Masterclass, 2015
Postoperative follow-up after colectomy for UC, 4th S-ECCO IBD Masterclass, 2015
Single port surgery in IBD, 4th S-ECCO IBD Masterclass, 2015
Type and timing of surgery in paediatric IBD, 4th S-ECCO IBD Masterclass, 2015
Postoperative follow-up for Crohn's, 4th S-ECCO IBD Masterclass, 2015
Outcomes of surgical management in childhood IBD, 4th S-ECCO IBD Masterclass, 2015
e-Course: Stricturing Crohn's Disease, ECCO e-Course, 2016
Ulcerative Colitis, ECCO Guidelines, 2016
Surgical CD, ECCO Guidelines, 2016
Surgery in IBD, 8th N-ECCO School, 2017
5.1. Understands the indications for surgery in active disease, and for complications including stricturing and penetrating disease
5.2. Understands the role of surgery in the management of disease-associated dysplasia
Pre- and postoperative management of Crohn's Disease, 15th IBD Intensive Advanced Course, 2017
5.3. Understands the importance of pre-operative optimisation.
Surgical and endoscopic FAQs in IBD: Case 1 - Preparing your patient for optimal surgery, ECCO Congress Scientific Programme, 2016
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Pre- and postoperative management of Crohn's Disease, 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
5.4. Understands the impact of concomitant medication on surgical outcome.
The microbiome: How can it affect surgery?, 4th S-ECCO IBD Masterclass, 2015
How does modern medical treatment affect surgical strategy?, 4th S-ECCO IBD Masterclass, 2015
Early salvage of the leaking ileo-anal anastomosis, 4th S-ECCO IBD Masterclass, 2015
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
Pre- and postoperative management of Crohn's Disease, 15th IBD Intensive Advanced Course, 2017
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
5.5. Understands different surgical approaches such as
- Methods of bowel-preserving surgery in CD
- The different long term options after subtotal colectomy in UC
Resection vs. strictureplasties for several short strictures, 4th S-ECCO IBD Masterclass, 2015
Two stage vs. three (or modified two) stage?, 4th S-ECCO IBD Masterclass, 2015
IRA vs. pouch surgery for medically refractory UC in young women, 4th S-ECCO IBD Masterclass, 2015
Combined approach for intestinal sparing in CD?, ECCO Congress Scientific Programme, 2017
The ileorectal anastomosis in UC: Time for a comeback? , ECCO Congress Scientific Programme, 2017
5.6. Recognises that early liaison with surgeons is important in high quality patient management
Surgical alternatives to biological therapy, ECCO Congress Scientific Programme, 2015
6. Treatment Options and Individualized Care
To understand the treatment options available and be able to discuss them appropriately to provide individualised patient care
The management of IBD, IBD Blue Book, 2014
Management of patients on thiopurines, ECCO Talking Heads, 2014
Topical therapy in IBD, IBD Boot Camp, 2014
Adalimumab, IBD Boot Camp, 2014
Certolizumab pegol, IBD Boot Camp, 2014
Infliximab, IBD Boot Camp, 2014
The role of 5ASA in mucosal healing, IBD Boot Camp, 2014
IBD therapy: Steroids, IBD Boot Camp, 2014
Medication for induction therapy in iBD, IBD Boot Camp, 2014
Mucosal Healing in Crohn's Disease, IBD Boot Camp, 2014
How to manage pouchitis, IBD Boot Camp, 2014
Therapeutic drug monitoring, ECCO Talking Heads, 2015
Methotrexate, why when and how, ECCO Talking Heads, 2015
Manipulating the microbiota in everyday practice , ECCO Congress Scientific Programme, 2016
Treatment of dysplasia (Tandem talk), 1st H-ECCO IBD Masterclass, 2016
The role of pathology in the evaluation of treatment, 1st H-ECCO IBD Masterclass, 2016
Treat to target in paediatric IBD - Same as in adults?, 4th P-ECCO Educational Course, 2017
Cannabis in adolescents - Any role? , 4th P-ECCO Educational Course, 2017
Vedolizumab in children and other biologics after TNF - What can we extrapulate? A case based discussion, 4th P-ECCO Educational Course, 2017
Workshop 1 - UC Management, 8th N-ECCO School, 2017
Workshop 2 - CD Management, 8th N-ECCO School, 2017
Personalised medicine: Dream or reality?, ECCO Congress Scientific Programme, 2017
Disease monitoring in IBD [soon], IBD Blue Book, [soon]
6.1. Knows the different treatment modalities for IBD taking into account disease extent, activity, previous history and complications
New algorithms for treating IBD, ECCO Congress Scientific Programme, 2015
Case based discussion: Investigation and management of mild Crohn's Disease, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Placing new molecules in the treatment pathway, ECCO Congress Scientific Programme, 2017
The long-term efficacy outside clinical trials, ECCO Congress Scientific Programme, 2017
The long-term safety outside clinical trials, ECCO Congress Scientific Programme, 2017
6.2. Knows the modes of delivery of different drug therapies and their advantages and disadvantages
New algorithms for treating IBD, ECCO Congress Scientific Programme, 2015
5-ASA compounds, 15th IBD Intensive Advanced Course, 2017
Thiopurines, 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents, 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab, 15th IBD Intensive Advanced Course, 2017
6.3. Recognises the importance of patient choice in deciding therapy and in helping to ensure adherence
New algorithms for treating IBD, ECCO Congress Scientific Programme, 2015
Session 1: Head-to-head comparative studies: Challenges & opportunities?, 2nd Advanced ECCO: EduCational COurse for Industry, 2016
Session 2: Patient reported outcomes measures, 2nd Advanced ECCO: EduCational COurse for Industry, 2016
Session 3: What challenges are faced by using cross-sectional imaging and histological endpoints in clinical trials, 2nd Advanced ECCO: EduCational COurse for Industry, 2016
Session 4: Disease-modification studies: Are we ready to start?, 2nd Advanced ECCO: EduCational COurse for Industry, 2016
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Medical treatment, 8th N-ECCO School, 2017
Adherence, 8th N-ECCO School, 2017
Treating the patient vs. treating the disease, ECCO Congress Scientific Programme, 2017
6.4. Understands the evidence base behind different therapeutic strategies and when they might be appropriate (conventional step care, optimised step up, top down and treat to target)
New algorithms for treating IBD, ECCO Congress Scientific Programme, 2015
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
6.5. Appreciates the monitoring requirements for specific therapies
New algorithms for treating IBD, ECCO Congress Scientific Programme, 2015
Monitoring therapy with drug levels and antibody testing, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Maximizing the bang for your buck: How to manage IBD on a minimum budget, ECCO Congress Scientific Programme, 2017
6.6. Appreciates common side effects and complications of therapy, their frequency and how to manage them
5-ASA compounds, 15th IBD Intensive Advanced Course, 2017
Thiopurines, 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents, 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab, 15th IBD Intensive Advanced Course, 2017
6.7. Appreciates the importance of on-going disease monitoring to confirm efficacy.
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
6.8. Understands when surgery is the most appropriate therapeutic option
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
Pre- and postoperative management of Crohn's Disease, 15th IBD Intensive Advanced Course, 2017
6.9. Is up to date with the evidence base from current clinical trial and real world data sets for the use of available therapies
The science behind biosimilars, ECCO Congress Scientific Programme, 2015
Experience with biosimilars from rheumatology, ECCO Congress Scientific Programme, 2015
Unanswered questions on biosimilars in IBD, ECCO Congress Scientific Programme, 2015
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
6.10. Has knowledge of the role of optimising therapy including interpretation of therapeutic drug monitoring for conventional and biological therapies.
Understanding pharmacokinetics and immunogenicity of anti-TNFs, ECCO Congress Scientific Programme, 2015
Applying pharmacokinetics in the daily care of patients: from combination therapy to therapeutic drug monitoring, ECCO Congress Scientific Programme, 2015
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing complications associated with anti-TNF therapy, 15th IBD Intensive Advanced Course, 2017
Maximizing the bang for your buck: How to manage IBD on a minimum budget, ECCO Congress Scientific Programme, 2017
6.11. Appreciates the role of stopping medical therapies in IBD and the appropriate timing / patient population in whom drugs can be stopped
Stopping drugs, ECCO Congress Scientific Programme, 2016
Managing complications associated with anti-TNF therapy, 15th IBD Intensive Advanced Course, 2017
7. Special situations
To understand the management of special situations in IBD
The medical management of Acute Severe Ulcerative Colitis: Case based discussion, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
Superinfection, 1st H-ECCO IBD Masterclass, 2016
Cancer risk in IBD, 1st H-ECCO IBD Masterclass, 2016
Pouchitis, 1st H-ECCO IBD Masterclass, 2016
Managing complications associated with anti-TNF therapy, 15th IBD Intensive Advanced Course, 2017
7.1. Understands the management of refractory proctitis
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
7.2. Understands the assessment and treatment of pouchitis
How to manage pouchitis, IBD Boot Camp, 2014
Management of refractory pouchitis , 15th IBD Intensive Advanced Course, 2017
7.3. Understands the management of stricturing Crohn's Disease
Ulcerative Colitis, ECCO Guidelines, 2016
e-Course: Stricturing Crohn's Disease, ECCO e-Course, 2016
Perform endoscopy and IBD incl. chromo-endoscopy, balloon dilatation , 15th IBD Intensive Advanced Course, 2017
7.4. Recognises specific medical and surgical requirements for fistulising and perianal CD
e-Course: Fistulising CD, ECCO e-Course, 2014
Surgical CD, ECCO Guidelines, 2016
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
7.5. Understands the principles of and evidence base for prevention of recurrence after surgery for CD
Surgical and endoscopic FAQs in IBD: Case 2 - Post-surgery prevention , ECCO Congress Scientific Programme, 2016
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
e-Course: Surgery in CD, ECCO e-Course, [soon]
7.6. Appreciates the options available for managing acute severe UC
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Medical management of acute severe Ulcerative Colitis, 15th IBD Intensive Advanced Course, 2017
7.7. Understands the problems associated with and the management of short bowel syndrome
Use of Nutritional therapy in IBD, ECCO Talking Heads, 2014
Nutrition & Paediatrics - topic: TBD, ECCO Talking Heads, 2017
7.8. Understands the problems associated with stomas
Nursing perspective: Stoma & Pouch, ECCO Talking Heads, 2016
7.9. Understands the assessment and management of oral and other extraintestinal sites of CD
Extra-Intestinal Manifestations, ECCO Guidelines, 2016
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Managing extraintestinal manifestations of IBD, 15th IBD Intensive Advanced Course, 2017
7.10. Understands the management of extraintestinal manifestations of IBD
Joint pain: arthritis and arthralgias , ECCO Congress Scientific Programme, 2015
Extra-Intestinal Manifestations, ECCO Guidelines, 2016
7.11. Understands the problems associated with the management of IBD in patients who are travelling
Travelling with IBD, ECCO Talking Heads, 2014
Vaccinations, immunisations and opportunistic infections in IBD - A case-based guide, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
7.12. Understands the management of inflammatory bowel disease in the elderly
e-Course: IBD in Elderly, ECCO e-Course, [soon]
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing complications associated with anti-TNF therapy, 15th IBD Intensive Advanced Course, 2017
8. Endoscopy in IBD
e-Course: Endoscopy for IBD, ECCO e-Course, 2014
The assessment of IBD according to ECCO Guidelines, IBD Blue Book, 2014
Endoscopy and imaging in IBD, IBD Boot Camp, 2014
Infliximab, IBD Boot Camp, 2014
Mucosal Healing in Crohn's Disease, IBD Boot Camp, 2014
Practical guide to endoscopy and IBD incl. chromo-endoscopy, balloon dilatation and reporting, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
e-Course: Endoscopy - UCEIS, ECCO e-Course, 2016
e-Course: Stricturing Crohn's Disease, ECCO e-Course, 2016
Imaging modalities in IBD [soon], IBD Blue Book, 2016
Perform endoscopy and IBD incl. chromo-endoscopy, balloon dilatation , 15th IBD Intensive Advanced Course, 2017
Disease monitoring in IBD [soon], IBD Blue Book, [soon]
8.1. Understands the core data that are required in an endoscopy report
8.2. Understands the different disease scoring systems that are used in clinical practice and research
8.3. Knows the principles of colorectal cancer surveillance in IBD
8.4. Knows the principles of chromoendoscopy and its application to IBD
8.5. Understands the appearances of and management of dysplasia during surveillance colonoscopy
Molecular basis of dysplasia and cancer, 1st H-ECCO IBD Masterclass, 2016
8.6. Understands the indications for and complications of stricture dilatation in IBD
8.7. Understands how to perform pouchoscopy
8.8. Understands the indications for small bowel capsule endoscopy and enteroscopy
8.9. Understands the indications for operative endoscopy in IBD
8.10. Understands the importance of close liaison with histopathologists in interpreting biopsies
9. Fistulising Crohn's Disease
To understand complex fistulising Crohn's Disease
e-Course: Fistulising CD, ECCO e-Course, 2014
Case based discussion: Fistulising & stenosing disease: Medical and surgical approaches, 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
Surgical CD, ECCO Guidelines, 2016
Case based discussion: Fistulizing Crohn's Disease: Medical and surgical approaches, 15th IBD Intensive Advanced Course, 2017
9.1. Knows the pathogenesis and complications of fistulising Crohn's Disease including perianal, enteroenteric, enterocutaneous, enterovesical and rectovaginal fistulae
9.2. Is aware of the importance of joint medical-surgical management of complex fistulae, and of nutritional support for high output fistulae
9.3. Understands the different imaging modalities for fistulising CD
9.4. Understands the different treatment modalities available for treatment of fistulae, including antibiotics, immunomodulators, biologics, surgical drainage and the possible combinations that may be required.
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
10. Reproductive Health, Pregnancy and Lactation
Understanding the effect of IBD and its treatment on reproductive health, pregnancy and lactation
e-Course: Pregnancy and IBD, ECCO e-Course, 2014
Reproduction & Pregnancy, ECCO Guidelines, 2015
IBD Drugs in Pregnancy - Current Controversies, ECCO Talking Heads, 2016
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
10.1. Knows the effect of active IBD, drug therapy and surgery on fecundity and pregnancy, specifically issues relating to immunosuppressants, biological therapy and surgery.
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
10.2. Knows the effect of IBD and its treatment on breastfeeding
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
10.3. Appreciates when to alter treatment to take account of pregnancy and breastfeeding
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
Treating the pregnant woman with IBD: Should anti-TFN be stopped during pregnancy? Should Vedolizumab be stopped during pregnancy?, ECCO Congress Scientific Programme, 2017
10.4. Knows the effects of the disease and its treatment on the chances of conception for men with IBD
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
10.5. Understand the issues relating to vaccination of neonates
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
10.6. Is able to provide appropriate advice about the effect of disease, treatment and surgery on fecundity, pregnancy and lactation
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
10.7. Understands the role of genetic counselling
Inflammatory pathways , 15th IBD Intensive Advanced Course, 2017
Inflammatory pathways , 15th IBD Intensive Advanced Course, 2017
5-ASA compounds , 15th IBD Intensive Advanced Course, 2017
Thiopurines , 15th IBD Intensive Advanced Course, 2017
Methotrexate, 15th IBD Intensive Advanced Course, 2017
Steroids, 15th IBD Intensive Advanced Course, 2017
Anti-TNF agents , 15th IBD Intensive Advanced Course, 2017
Vedolizumab, 15th IBD Intensive Advanced Course, 2017
Ustekinumab , 15th IBD Intensive Advanced Course, 2017
Managing IBD and pregnancy , 15th IBD Intensive Advanced Course, 2017
11. Co-Morbidity and IBD
Understanding of the effects of concurrent medical conditions on the treatment of IBD
Opportunistic Infections, ECCO Guidelines, 2014
e-Course: IBD in Elderly, ECCO e-Course, [soon]
Bone health in IBD - Does it concern paediatricians?, 4th P-ECCO Educational Course, 2017
Managing complications associated with anti-TNF therapy, 15th IBD Intensive Advanced Course, 2017
11.1. Knows the importance of assessing co-morbidities in patients with IBD
The elderly patient with IBD: Should Azathiorprine ever be used in the elderly? Should the type of surgery be different in an elderly patient?, ECCO Congress Scientific Programme, 2017
11.2. Knows the risks relating to a previous history of malignancy or the development of malignancy in IBD, in particular how this affects treatment options.
The use of IBD medicine in patients with cancer: Which treatment should be stopped when cancer is diagnosed? Which treatment to use in a patient with a prior diagnosis with cancer?, ECCO Congress Scientific Programme, 2017
11.3. Knows the risks relating to infections such as tuberculosis, hepatitis B, hepatitis C and HIV in relation to the treatment of IBD
11.4. Knows the circumstances in which patients should be screened for or immunised against infectious diseases before commencing therapy
11.5. Is aware of the appropriate investigations and vaccination strategy for patients with a new diagnosis of IBD
12. Nutrition
To understand the nutritional principles underlying IBD
Nutritional and medical treatment of IBD in children - Case 1: Ileocaecal disease, 4th S-ECCO IBD Masterclass, 2015
Nutritional and medical treatment of IBD in children- Case 2: Pancolitis, 4th S-ECCO IBD Masterclass, 2015
Diet, environment and genetics in IBD, 1st D-ECCO Workshop, 2016
Microbiota and IBD, 1st D-ECCO Workshop, 2016
Nutritional assessment in IBD patients , 1st D-ECCO Workshop, 2016
The evidence for fibre and prebiotics in IBD , 1st D-ECCO Workshop, 2016
Session 1: Panel Q&A, 1st D-ECCO Workshop, 2016
Session 2: Panel Q&A, 1st D-ECCO Workshop, 2016
Session 3: Panel Q&A, 1st D-ECCO Workshop, 2016
Nutrition & Paediatrics - topic: TBD, ECCO Talking Heads, 2017
e-Course: Use of exclusive enteral nutrition in CD, ECCO e-Course, [soon]
12.1. Knows the role of nutrition as a therapy for active IBD
Nutritional assessment in IBD, 8th N-ECCO School, 2017
Nutritional management in IBD, 8th N-ECCO School, 2017
12.2. Knows the role of dietary intervention in the management of symptoms associated with active IBD
12.3. Understands the role of nutritional manipulation to treat non inflammatory symptoms of IBD
Exclusive and partial enteral nutrition in IBD, 1st D-ECCO Workshop, 2016
New dietary therapies in IBD, 1st D-ECCO Workshop, 2016
Iron deficiency anaemia in IBD, 1st D-ECCO Workshop, 2016
Dietary treatment of functional symptoms in IBD, 1st D-ECCO Workshop, 2016
Environmental factors as therapy (diet modification; EEN feeding), ECCO Congress Scientific Programme, 2017
12.4. Knows the mechanisms of nutritional deficiency in IBD (including vitamin deficiency) and the role of nutritional support
12.5. Understands the circumstances when nutritional support should be provided by enteral or parenteral routes, the various methods of delivery and the complications associated with nutritional support
Dietary treatment in short bowel syndrome/intestinal insufficiency, 1st D-ECCO Workshop, 2016
12.6. Understands the possible methods of maximising bowel preservation including appropriate medical therapy, endoscopic therapy and bowel preserving surgery.
13. Psycho-social effects of disease
IBD quality standards: Delphi consensus, 9th N-ECCO Network Meeting , 2015
Tailored communication in compliance, 9th N-ECCO Network Meeting , 2015
The patient with psychological comorbidities: How to wean off opiates in these patients? Is there any preference in drugs?, ECCO Congress Scientific Programme, 2017
13.1. Understands the effects of IBD on educational achievement
13.2. Understands the effects of IBD on work and careers
13.3. Understands how IBD can result in disability
13.4. Understands the burden of psychological morbidity in IBD and how to treat it
13.5. Understands the effects of IBD on relationships and sexual function
13.6. Understands the effects of IBD on social activities
Psychosocial implications of living with IBD, 8th N-ECCO School, 2017
14. Non-inflammatory Symptoms in IBD
To understand the aetiology and treatment of non-inflammatory symptoms in IBD
The IBD and IBS interface, 9th N-ECCO Network Meeting , 2015
14.1. Understands the mechanisms by which IBD can cause fatigue and how this can be managed
Algorithm for the management of fatigue, ECCO Congress Scientific Programme, 2015
14.2. Understands the mechanisms by which IBD can cause non inflammatory pain and how this can be managed
14.3. Understands the prevalence of IBS (functional symptoms) in IBD and how to manage them
Algorithm for abdominal pain management, ECCO Congress Scientific Programme, 2015
14.4. Understands the prevalence of incontinence in IBD and how to manage it
15. Paediatric to Adult Transition
To understand the issues facing adolescents with IBD and the handover of care to adult gastroenterologists
Paediatric UC, ECCO Guidelines, 2012
When does a child with IBD become an adult?, 4th S-ECCO IBD Masterclass, 2015
Paediatric and adolescent IBD, 1st H-ECCO IBD Masterclass, 2016
e-Course: Transition, ECCO e-Course, [soon]
15.1. Appreciates the differences in approach between paediatric and adult IBD management
Should clinical trials in children be different? , ECCO Congress Scientific Programme, 2016
The child with IBD: Should anti-TFN be used as a mono-therapy in children (safety risk)? Who should (be allowed) to operate on the children in IBD?, ECCO Congress Scientific Programme, 2017
15.2. Knows the importance of maintaining adequate growth
Very early onset IBD - from research to bedside , ECCO Congress Scientific Programme, 2016
15.3. Knows the importance of minimising the adverse of effects of IBD on education
15.4. Has awareness of the particular issues concerning IBD in adolescents and appreciates the practical problems in transition to adult care
15.5. Is aware of the different models of paediatric to adult transition in IBD
16. Novel Therapies
Experience novel therapies in IBD, and of clinical trials used to pilot their introduction
Tandem talk: IBD therapeutic targets and drugs: New and old , 13th IBD Intensive Advanced Course for Junior Gastroenterologists, 2015
Faecal transplantation for UC?, 9th N-ECCO Network Meeting , 2015
Stem-cell transplantation: Hope or expectation?, 9th N-ECCO Network Meeting , 2015
Medical therapies around the corner, 9th N-ECCO Network Meeting , 2015
Clinical trial terminology & processes. Standard investigations, 1st School for Clinical Trialists, 2016
How to optimise recruitment to clinical trials in IBD, 1st School for Clinical Trialists, 2016
Tips & tricks for the IBD clinical research team, 1st School for Clinical Trialists, 2016
What does the future hold for IBD clinical trials, 1st School for Clinical Trialists, 2016
New treatments targeting the microbiota (FMT, antibiotics) - A case based discussion, 4th P-ECCO Educational Course, 2017
16.1. Understands the different types of evidence - clinical trial / cohort study / systematic review etc.
How to set-up a successful translational IBD unit - Providing the frame for future discovery, 5th SciCom Workshop: Methodology on Research, 2017
Studying the microbiota - Bacteria and beyond, 5th SciCom Workshop: Methodology on Research, 2017
Omics analysis - Can we see the forest for the trees, 5th SciCom Workshop: Methodology on Research, 2017
Transgenic animal models in IBD - Tricks you cannot read in the manuscripts, 5th SciCom Workshop: Methodology on Research, 2017
Recreating the intestine ex vivo - Where are we on the way to the artificial gut , 5th SciCom Workshop: Methodology on Research, 2017
Studying drug response - Translation of system biology to systems medicine, 5th SciCom Workshop: Methodology on Research, 2017
Trial endpoint vs. therapeutic objectives, ECCO Congress Scientific Programme, 2017
16.2. Knows the evidence that supports the use of currently unlicensed therapies in IBD
Positioning of the new molecules in practice, ECCO Congress Scientific Programme, 2015
The science which will impact our IBD clinic, ECCO Congress Scientific Programme, 2015
Haematopoietic stem cell transplantation, ECCO Congress Scientific Programme, 2016
Immune cell manipulation, ECCO Congress Scientific Programme, 2016
Future strategies to change the flora , ECCO Congress Scientific Programme, 2016
Placing new molecules in the treatment pathway, ECCO Congress Scientific Programme, 2017
JAK-inhibitors, ECCO Congress Scientific Programme, 2017
S1P, ECCO Congress Scientific Programme, 2017
Anti IL12/IL23 compounds, ECCO Congress Scientific Programme, 2017